Kris Renton Named Chief Commercial Officer at NovApproach Spine

NovApproach Spine has appointed spine industry executive Kris Renton as chief commercialization officer.

Renton will leverage more than 25 years of experience specializing in spine sales, including leadership positions with industry giants NuVasive Inc., Stryker Corp., and Zimmer Biomet Holdings Inc. He joins the implant developer at a high-growth stage of its early commercialization process.

“It’s a pleasure to welcome Kris, as we begin a new year with ambitious growth goals,” NovApproach Spine CEO Raymond Cloutier said. “I believe his character qualities, wealth of relationships in the industry, and keen understanding of the technical and business aspects of spine make him a perfect fit for our team and will help more surgeons and their patients across the country benefit from our technology.”

Renton’s strategic sales plan introduces significant new surgeon, distributor, and hospital engagement initiatives, designed to exponentially increase the company’s reach and service level.

“Seldom do you get an opportunity to solve a career-long problem in the spine space. NovApproach Spine does just that,” Renton stated. “I’m eager to build on the company’s offering of versatility, as we give surgeons the opportunity to select their distributing partner of choice, while also seeking new distributors who have a passion for providing the best in patient care. We’ll be expanding our reach into teaching institutions, enhancing medical education and clinical support, and looking for thought leaders to share how NovApproach Spine supports their approach to spine surgery.”

NovApproach Spine is a spinal implant solutions company located in Alachua, Fla. Its OneLIF device gives surgeons versatility for anterior lumbar spine surgery.